SAB Biotherapeutics (NASDAQ:SABS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does SAB Biotherapeutics (SABS) operate in?

SAB Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

SAB Biotherapeutics Stock (NASDAQ: SABS) stock price, news, charts, stock research, profile.

Open	$3.61
Close	$4.10
Volume / Avg.	120.12K / 76.58K
Day Range	$3.36 - $4.17
52 Wk Range	2.16 - 6.30
Market Cap	$37.84M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	0.52%
Days to Cover	1

Recent News

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Applied Therapeutics, Inc.

Avi Kapoor

Cal-Maine Foods, UniFirst And 3 Stocks To Watch Heading Into Wednesday

With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Avi Kapoor

VerifyMe And 3 Other Stocks Under $2 Insiders Are Buying

The Dow Jones closed higher by more than 500 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Sep 24

Oct 24

Nov 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.61
Close	$4.10
Volume / Avg.	120.12K / 76.58K
Day Range	$3.36 - $4.17
52 Wk Range	2.16 - 6.30
Market Cap	$37.84M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	0.52%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy SAB Biotherapeutics (SABS) stock?

You can purchase shares of SAB Biotherapeutics (NASDAQ:SABS) through any online brokerage.

View our list of the best stock brokerages

Who are SAB Biotherapeutics (SABS) competitors?

Other companies in SAB Biotherapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), OncoCyte (NASDAQ:OCX), Intensity Therapeutics (NASDAQ:INTS), Curis (NASDAQ:CRIS) and Longeveron (NASDAQ:LGVN).

What is the forecast, or price target, for SAB Biotherapeutics (SABS) stock?

SAB Biotherapeutics has a consensus price target of $12.40.

What is the current price for SAB Biotherapeutics (SABS)?

The stock price for SAB Biotherapeutics (NASDAQ: SABS) is $4.1 last updated January 24, 2025 at 4:00 PM EST.

Does SAB Biotherapeutics (SABS) pay a dividend?

There are no upcoming dividends for SAB Biotherapeutics.

When is SAB Biotherapeutics (NASDAQ:SABS) reporting earnings?

SAB Biotherapeutics’s Q4 earnings are confirmed for Friday, March 28, 2025.

Is SAB Biotherapeutics (SABS) going to split?

There is no upcoming split for SAB Biotherapeutics.

What sector and industry does SAB Biotherapeutics (SABS) operate in?

SAB Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

SAB Biotherapeutics

SAB Biotherapeutics (SABS) Forecast